SK4052003A3 - Oral pharmaceutical composition and use thereof - Google Patents

Oral pharmaceutical composition and use thereof Download PDF

Info

Publication number: SK4052003A3
Authority: SK; Slovakia
Prior art keywords: layer; pseudoephedrine; pharmaceutically acceptable; tablet; effective amount
Prior art date: 2000-10-06

Application number

SK405-2003A

Other languages

English (en)

Slovak (sk)

Inventor

Sara Abelaira

Daniel Bianchi

Francisco Gel

Victor Denker

Mabel Fernandez

Vidal Marta Cicconi De

Original Assignee

Boehringer Ingelheim Int

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-10-06

Filing date

2001-09-28

Publication date

2003-09-11

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8170029&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SK4052003(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-09-28 Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int

2003-09-11 Publication of SK4052003A3 publication Critical patent/SK4052003A3/sk

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/08—Antibacterial agents for leprosy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Pulmonology (AREA)
Immunology (AREA)
Oncology (AREA)
Ophthalmology & Optometry (AREA)
Otolaryngology (AREA)
Communicable Diseases (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

SK405-2003A 2000-10-06 2001-09-28 Oral pharmaceutical composition and use thereof SK4052003A3 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP00121828		2000-10-06
PCT/EP2001/011229 WO2002028373A1 (en)	2000-10-06	2001-09-28	New pharmaceutical compositions containing epinastine and pseudoephedrine

Publications (1)

Publication Number	Publication Date
SK4052003A3 true SK4052003A3 (en)	2003-09-11

Family

ID=8170029

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SK405-2003A SK4052003A3 (en)	2000-10-06	2001-09-28	Oral pharmaceutical composition and use thereof

Country Status (31)

Country	Link
EP (1)	EP1326586B1 (de)
JP (1)	JP2004521864A (de)
KR (1)	KR20030036894A (de)
CN (1)	CN1291715C (de)
AR (2)	AR032479A1 (de)
AT (1)	ATE424813T1 (de)
AU (2)	AU2002212290B2 (de)
BG (1)	BG107686A (de)
BR (1)	BR0114339A (de)
CA (1)	CA2423288C (de)
CZ (1)	CZ2003945A3 (de)
DE (1)	DE60137952D1 (de)
EA (1)	EA007288B1 (de)
EC (1)	ECSP034513A (de)
EE (1)	EE200300138A (de)
ES (1)	ES2323570T3 (de)
HR (1)	HRP20030259A2 (de)
HU (1)	HUP0300970A3 (de)
IL (1)	IL154884A0 (de)
ME (1)	MEP39708A (de)
MX (1)	MXPA03002900A (de)
MY (1)	MY131159A (de)
NO (1)	NO20031537L (de)
NZ (1)	NZ525653A (de)
PE (1)	PE20020324A1 (de)
PL (1)	PL366123A1 (de)
SK (1)	SK4052003A3 (de)
UA (1)	UA75896C2 (de)
WO (1)	WO2002028373A1 (de)
YU (1)	YU24603A (de)
ZA (1)	ZA200302079B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MXPA03011705A (es) *	2001-06-20	2004-03-19	Schering Corp	Antihistaminas para el tratamiento de congestion nasal y obstruccion nasal.
JP4549618B2 (ja) *	2001-11-22	2010-09-22	第一三共ヘルスケア株式会社	鼻炎用組成物
BR0313175A (pt) *	2002-08-02	2005-06-14	Boehringer Ingelheim Int	Formulações farmacêuticas compreendendo combinações de epinastina, pseudoefedrina e metilefedrina
JP5021155B2 (ja) *	2003-08-01	2012-09-05	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	エピナスチンと１種以上のさらなる抗−ｈ１−ヒスタミン類との組合せを含む皮膚疾患治療用製薬組成物
EP1750717B1 (de) *	2004-02-11	2017-07-19	Rubicon Research Private Limited	Pharmazeutische zusammensetzungen mit kontrollierter freisetzung und verbesserter bioverfügbarkeit

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0903151A1 (de) *	1997-09-22	1999-03-24	ASTA Medica Aktiengesellschaft	Verwendung von Kombinationen enthaltend nichtsedierende Antihistaminika und Alfa-Adrenergische Agonisten für die topische Behandlung von Rhinitis/Konjunktivitis sowie Erkältungs- und Grippe-Symptomen
PL193131B1 (pl) *	1997-12-23	2007-01-31	Schering Corp	Kompozycja farmaceutyczna zawierająca kombinację składników aktywnych i jej zastosowanie
AU6252699A (en) *	1998-10-09	2000-05-01	Schering Corporation	Composition and method for treating allergic diseases
US6613357B2 (en) *	2000-01-13	2003-09-02	Osmotica Corp.	Osmotic device containing pseudoephedrine and an H1 antagonist

2001
- 2001-09-04 PE PE2001000883A patent/PE20020324A1/es not_active Application Discontinuation
- 2001-09-28 AT AT01980449T patent/ATE424813T1/de active
- 2001-09-28 WO PCT/EP2001/011229 patent/WO2002028373A1/en not_active Ceased
- 2001-09-28 DE DE60137952T patent/DE60137952D1/de not_active Expired - Lifetime
- 2001-09-28 UA UA2003054060A patent/UA75896C2/uk unknown
- 2001-09-28 SK SK405-2003A patent/SK4052003A3/sk unknown
- 2001-09-28 EP EP01980449A patent/EP1326586B1/de not_active Expired - Lifetime
- 2001-09-28 MX MXPA03002900A patent/MXPA03002900A/es active IP Right Grant
- 2001-09-28 HU HU0300970A patent/HUP0300970A3/hu unknown
- 2001-09-28 YU YU24603A patent/YU24603A/sh unknown
- 2001-09-28 AU AU2002212290A patent/AU2002212290B2/en not_active Ceased
- 2001-09-28 BR BR0114339-5A patent/BR0114339A/pt not_active Application Discontinuation
- 2001-09-28 NZ NZ525653A patent/NZ525653A/en unknown
- 2001-09-28 ES ES01980449T patent/ES2323570T3/es not_active Expired - Lifetime
- 2001-09-28 IL IL15488401A patent/IL154884A0/xx unknown
- 2001-09-28 JP JP2002531999A patent/JP2004521864A/ja active Pending
- 2001-09-28 EE EEP200300138A patent/EE200300138A/xx unknown
- 2001-09-28 EA EA200300430A patent/EA007288B1/ru not_active IP Right Cessation
- 2001-09-28 CN CNB018169376A patent/CN1291715C/zh not_active Expired - Lifetime
- 2001-09-28 AU AU1229002A patent/AU1229002A/xx active Pending
- 2001-09-28 ME MEP-397/08A patent/MEP39708A/xx unknown
- 2001-09-28 CA CA002423288A patent/CA2423288C/en not_active Expired - Lifetime
- 2001-09-28 KR KR10-2003-7004846A patent/KR20030036894A/ko not_active Ceased
- 2001-09-28 CZ CZ2003945A patent/CZ2003945A3/cs unknown
- 2001-09-28 HR HR20030259A patent/HRP20030259A2/hr not_active Application Discontinuation
- 2001-09-28 PL PL01366123A patent/PL366123A1/xx unknown
- 2001-10-04 MY MYPI20014635A patent/MY131159A/en unknown
- 2001-10-05 AR ARP010104692A patent/AR032479A1/es not_active Application Discontinuation
2003
- 2003-03-13 EC EC2003004513A patent/ECSP034513A/es unknown
- 2003-03-14 ZA ZA200302079A patent/ZA200302079B/en unknown
- 2003-03-28 BG BG107686A patent/BG107686A/bg unknown
- 2003-04-04 NO NO20031537A patent/NO20031537L/no not_active Application Discontinuation
2012
- 2012-07-19 AR ARP120102612A patent/AR087240A2/es unknown

Also Published As

Publication number	Publication date
AR087240A2 (es)	2014-03-12
EA200300430A1 (ru)	2003-10-30
AR032479A1 (es)	2003-11-12
CA2423288A1 (en)	2002-04-11
HUP0300970A3 (en)	2005-03-29
HUP0300970A2 (hu)	2003-11-28
HK1062196A1 (en)	2004-10-21
ZA200302079B (en)	2004-05-05
PE20020324A1 (es)	2002-06-18
CA2423288C (en)	2007-11-13
EP1326586B1 (de)	2009-03-11
AU1229002A (en)	2002-04-15
ES2323570T3 (es)	2009-07-21
CN1468094A (zh)	2004-01-14
NO20031537L (no)	2003-06-04
YU24603A (sh)	2006-05-25
HRP20030259A2 (en)	2005-02-28
MXPA03002900A (es)	2003-09-10
CZ2003945A3 (cs)	2003-08-13
WO2002028373A1 (en)	2002-04-11
EE200300138A (et)	2003-08-15
PL366123A1 (en)	2005-01-24
ECSP034513A (es)	2003-04-25
MEP39708A (en)	2011-02-10
EP1326586A1 (de)	2003-07-16
KR20030036894A (ko)	2003-05-09
BG107686A (bg)	2003-11-28
IL154884A0 (en)	2003-10-31
ATE424813T1 (de)	2009-03-15
NZ525653A (en)	2006-07-28
NO20031537D0 (no)	2003-04-04
EA007288B1 (ru)	2006-08-25
JP2004521864A (ja)	2004-07-22
DE60137952D1 (de)	2009-04-23
AU2002212290B2 (en)	2006-08-03
MY131159A (en)	2007-07-31
BR0114339A (pt)	2003-12-09
CN1291715C (zh)	2006-12-27
UA75896C2 (en)	2006-06-15

Publication	Publication Date	Title
MXPA00012957A (es)	2003-06-19	Composicion para dosis oral de liberacion extendida.
RU2614382C2 (ru)	2017-03-24	Стабильная фармацевтическая композиция для перорального введения, включающая левоцетиризин или его фармацевтически приемлимую соль, и монтелукаст или его фармацевтически приемлимую соль
HUP0400386A2 (hu)	2004-08-30	Cetirizint és pszeudoefedrint tartalmazó tabletta és alkalmazása gyógyszerkészítmények előállítására
US7022341B2 (en)	2006-04-04	Pharmaceutical compositions containing epinastine and pseudoephedrine
US20030228359A1 (en)	2003-12-11	Pharmaceutical formulations containing epinastine, belladonna, and pseudoephedrine
SK4052003A3 (en)	2003-09-11	Oral pharmaceutical composition and use thereof
US20080095846A1 (en)	2008-04-24	Pharmaceutical compositions of antihistamine and decongestant
AU2002212290A1 (en)	2002-06-27	New pharmaceutical compositions containing epinastine and pseudoephedrine
US20040068000A1 (en)	2004-04-08	Compression coated tablets
EP1490034B1 (de)	2007-06-27	Pharmazeutische zusammensetzungen enthaltend eine antihistaminische abschwellende arzneistoffkombination und ein verfahren zur herstellung davon
US20050084527A1 (en)	2005-04-21	Pharmaceutical formulations containing combinations of epinastine, pseudoephedrine, and methylephedrine
US20050008703A1 (en)	2005-01-13	Medical formulation containing a muscarinic agonist
US20060122194A1 (en)	2006-06-08	Tablet comprising efletirizine and pseudoephedrine
TWI280884B (en)	2007-05-11	New pharmaceutical compositions containing epinastine and pseudoephedrine
WO2006052227A1 (en)	2006-05-18	High-dosage extended-release formulation of gepirone
US20060099267A1 (en)	2006-05-11	High-dosage extended-release formulation of gepirone
KR20060108696A (ko)	2006-10-18	Ｌｔｂ4 길항제를 함유하는 약제학적 제형, 이의 제조방법및 이의 용도
JP2006509789A (ja)	2006-03-23	不安症治療法及び治療薬